| P2P Service Delivery (SD) Lead NGSC |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
07 Oktober 2024 |
| Finance Control and Compliance US Manager |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
08 Oktober 2024 |
| General Accounting Manager |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
09 Oktober 2024 |
| Procure to Pay Business Partner Management |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
16 Oktober 2024 |
| Senior Financial Reporting and Accounting Specialist |
Prague |
Czech Republic |
Finance |
CTS |
Audit & Finance |
03 Juli 2024 |
| P2P & T&E Specialist (Arabic Speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
05 Juli 2024 |
| Commercial & Medical Excellence Manager (f/m/d) |
Vienna |
Austria |
Finance |
Innovative Medicines |
Data and Digital |
15 Oktober 2024 |
| Tax Manager m/w/d) |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
Finance |
Corporate |
Audit & Finance |
16 Oktober 2024 |
| Tax Specialist (m/w/d) |
Schaftenau |
Austria |
Finance |
CTS |
Audit & Finance |
22 Juli 2024 |
| Global Digital FRA Automation Lead |
Hyderabad (Office) |
India |
Finance |
Corporate |
Audit & Finance |
20 Juni 2024 |
| R2R Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
28 Juli 2024 |
| Business Planning and Analysis Manager, Novartis Technical Operations |
INSURGENTES |
Mexico |
Finance |
Innovative Medicines |
Audit & Finance |
22 Augustus 2024 |
| Senior Accountant, Tax |
Shanghai (Shanghai) |
China |
Finance |
Corporate |
Audit & Finance |
29 Augustus 2024 |
| R2R Lead Israel |
Israel |
Israel |
Finance |
CTS |
Audit & Finance |
16 September 2024 |
| S2P Business Partner (Korean speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
24 September 2024 |
| Senior Manager ERP Assurance |
Hyderabad (Office) |
India |
Finance |
CTS |
Audit & Finance |
23 September 2024 |
| Financial Accounting Specialist (m/w/d) |
Schaftenau |
Austria |
Finance |
CTS |
Audit & Finance |
13 September 2024 |
| P2P & T&E Specialist (Japanese speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
05 Juni 2024 |
| R2R Senior Specialist GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
13 Juni 2024 |
| P2P & T&E Business Partner (Japanese speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
12 Juni 2024 |
| Corporate Tax Manager |
Amiria |
Egypt |
Finance |
Corporate |
Audit & Finance |
31 Mei 2024 |
| Treasury & Cash Management Team Lead |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
12 Augustus 2024 |
| Associate Director, US Federal and State Tax Reporting |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
06 September 2024 |
| Long term Finance Internship |
İstanbul Kavacık |
Turkey |
Finance |
Innovative Medicines |
Others |
10 September 2024 |
| BPA Planning Process, RLT |
Baarle Nassau |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
05 Augustus 2024 |
| ERP Assurance Senior Consultant-2 |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
20 Augustus 2024 |
| R2R Senior Specialist - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
19 Augustus 2024 |
| R2R Senior Specialist |
Bucuresti |
Romania |
Finance |
CTS |
Audit & Finance |
05 September 2024 |
| BPA & R2R Analyst |
Amsterdam |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
04 September 2024 |
| RLT Sasayama_Associate_Finance Business Planning and Analysis |
Sasayama |
Japan |
Finance |
Innovative Medicines |
Audit & Finance |
17 September 2024 |
| Financial Analyst - SoD Ops |
Hyderabad (Office) |
India |
Finance |
Corporate |
Audit & Finance |
17 September 2024 |
| Senior FRA Specialist GL |
Prague |
Czech Republic |
Finance |
CTS |
Audit & Finance |
26 September 2024 |
| Comptable Général(e) Expérimenté(e) H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Finance |
CTS |
Audit & Finance |
27 September 2024 |
| R2R Senior Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
02 Oktober 2024 |
| R2R Senior Specialist - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
08 Oktober 2024 |
| Expert Analyst – Management Reporting |
Prague |
Czech Republic |
Finance |
Corporate |
Audit & Finance |
08 Oktober 2024 |
| Global Finance Master Data Sr Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
08 Oktober 2024 |
| Site Finance Head |
Morris Plains |
USA |
Finance |
Innovative Medicines |
Audit & Finance |
04 Oktober 2024 |
| R2R Team Lead - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
10 Oktober 2024 |
| BPA (Budget & Planning Analyst) |
İstanbul Kurtköy |
Turkey |
Finance |
Innovative Medicines |
Audit & Finance |
10 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Taiyuan (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
24 September 2024 |
| 县域主任(主管) |
Luoyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
26 September 2024 |
| (高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
29 September 2024 |
| Therapy Area Partner |
Abha |
Saudi Arabia |
International |
Innovative Medicines |
Sales |
01 Oktober 2024 |
| RWE Lead H/F CDD 12 mois |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Research & Development |
04 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
09 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Sales |
09 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Nanjing (Jiangsu Province) |
China |
International |
Innovative Medicines |
Sales |
10 Oktober 2024 |
| Expert Développement des Compétences - Visite Médicale H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Sales |
11 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
11 Oktober 2024 |